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Abstract Two hitherto unknown lanostane-type triterpenoids, namely scillascillol (1) and scillascillone (2), and a
hitherto unknown norlanostane-triterpene glycoside, namely scillascilloside B-1 (3), were isolated from the ethanol extract
of the whole plants of Scilla scilloides. Their structures were elucidated on the basis of extensive spectroscopic studies. In
addition, the structure of drimiopsin D (6a) has been revised as 2,5-dimethoxy-8-methyl-1,3,6-trihydroxyxanthone (6) by
reanalysis of the spectroscopic data.
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1 Introduction
Scilla scilloides (Lindl.) Druce is a perennial herb
belonging to the Liliaceae family, also compiled in Hya-
cinthaceae family in the relatively new classification sys-
tem [1]. The bulbs or the whole plants have been used as a
foodstuff, a traditional Chinese medicine for promoting
blood circulation, an analgesic, an anti-inflammatory agent,
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and treatment of heart failure and arrhythmia [2]. Previous
chemical investigations on S. scilloides reported homo-
isoflavones, lanostane-type and norlanostane-type triter-
penoids, xanthones, lignans, etc. [3–10]. As part of a
BioBioPha (http://www.chemlib.cn) objective to assemble
a large-scale natural product library valuable in the dis-
covery of new drug leads from nature [11–14], the phyto-
chemical investigation on the whole plants of S. scilloides
led to isolation of two new lanostane-type triterpenoids,
namely scillascillol (1) and scillascillone (2), a new nor-
lanostane-triterpene glycoside, namely scillascilloside B-1
(3), together with two known norlanostanes, 15-deoxoeu-
costerol (4) [4] and 3-dehydro-15-deoxoeucosterol (5) [4],
and three known xanthones, drimiopsin D (6) [15], drim-
iopsin C (7) [15] and norlichexanthone (8) [16] (Fig. 1).
This paper describes the isolation and structural elucidation
of new lanostane-type triterpenoids and structure revision
of a xanthone drimiopsin D.
2 Results and Discussion
Compound 1 was obtained as a white amorphous powder. Its
molecular formula was determined to be C30H46O6 on the
basis of negative-ion HRESIMS at m/z 501.3207 [M - H]-
(calcd for C30H45O6, 501.3216). The IR absorption bands at
3441, 3432 and 1765 cm-1 suggested the presence of
hydroxy and carbonyl functionalities, respectively. The 1H
NMR spectrum (Table 1) of 1 indicated signals due to four
tertiary methyls [dH 0.89 (s), 1.01 (s), 1.24 (s), 1.52 (s)], two
secondary methyls [dH 1.07 (d, J = 6.8 Hz); 1.47 (d,
J = 7.1 Hz)], a pair of oxygenated methylene protons [dH
3.70, 4.56 (each d, J = 11.0 Hz)], and two oxygenated
methine protons [dH 3.61 (dd, J = 11.6, 4.4 Hz); 4.34 (d,
J = 4.4 Hz)]. The 13C NMR and DEPT spectrum (Table 1)
exhibited 30 carbon signals, including an ester carbonyl
resonance at [dC 178.9 (s)], a tetra-substituted double bond
at [dC 135.1 (s), 134.9 (s)], and five oxygenated carbons at
[dC 64.5 (t), 77.4 (d), 80.0 (d), 99.2 (s), 117.0 (s)]. By ana-
lyzing the above signals, especially the set of particular
quaternary carbons [dC 99.2, 117.0, 178.9] and an oxy-
genated methine [dH 4.34 (d, J = 4.4 Hz); dC 77.4 (d)],
compound 1 was presumed as a kind of characteristic
lanostane triterpenoid derived from this genus. The above
NMR spectroscopic features of 1 were very similar to those
of scillasaponin D [17] and scillasaponin G [18], except lack
of the signals due to the sugar moiety and an up-field shift
about 10 ppm of the 13C NMR signal at C-3 of 1. Based on
analysis of the above spectral data, a planar structure of 1
was assumed, which was also confirmed by the HMBC
(Fig. 2) correlations from H-3 to C-1 and C-29, from Me-19
to C-1 and C-9, as well as from Me-28 and H-29 to C-3.
Fig. 1 Structures of compounds 1–8
264 F.-C. Ren et al.
123
Taking into account its biological source and characteristic
NMR data (including chemical shifts and coupling con-
stants) of the spiro rings, the stereochemistry of 1 should be
consistent with those analogues reported from this genus [8].
The hydroxy group at C-3 was equatorial (b) according to an
axial–axial coupling between H-3 and H-2b (J = 11.6 Hz)
and an axial-equatorial coupling between H-3 and H-2a
(J = 4.4 Hz), which was also supported by the ROESY
(Fig. 2) correlations of H-3 $ H-5 and H-3 $ Me-28.
Considering a relatively good rigid property of spiro rings,
the determination of its stereochemistry was able to be
conducted on the basis of ROESY analysis. The ROESY
Table 1 NMR spectroscopic data of scillascillol (1) and scillascillone (2) in pyridine-d5 (dH 8.71, dC 149.9 ppm)
No. 1 2
dH dC dH dC
1 1.19 (td, 13.3, 3,4, H-a) 35.8 t 1.48 (td, 13.1, 4.4, H-a) 37.1 t
1.69 (dt, 13.3, 3.4, H-b) 1.90 (ddd, 13.1, 5.6, 2.9, H-b)
2 1.95 (m) 29.0 t 2.37 (ddd, 14.2, 4.4, 2.9, H-a) 36.3 t
2.03 (m) 2.86 (td, 14.2, 5.7, H-b)
3 3.61 (dd, 11.6, 4.4) 80.0 d 214.5 s
4 43.2 s 55.0 s
5 1.26 (dd, 12.8, 1.6) 51.5 d 1.69 (m) 53.2 d
6 1.49 (m) 18.9 t 1.69 (m) 19.7 t
1.81 (m) 1.77 (m)
7 1.99 (m) 26.8 t 2.01 (m) 26.5 t
8 135.1 s 135.9 s
9 134.9 s 134.2 s
10 37.2 s 37.2 s
11 1.99 (m) 21.0 t 2.01 (m) 21.1 t
2.13 (m) 2.05 (m)
12 1.42 (m) 24.9 t 1.44 (m) 24.9 t
2.25 (dt, 13.0, 9.0) 2.25 (dt, 13.2, 8.7)
13 48.8 s 48.7 s
14 50.7 s 50.7 s
15 1.32 (br. t, 10.6) 31.9 t 1.31 (br. t, 10.2) 31.8 t
1.65 (br. d, 9.1) 1.64 (m)
16 1.82 (m) 37.8 t 1.82 (ddd, 14.7, 11.1, 1.5) 37.7 t
2.65 (dt, 14.5, 8.9) 2.65 (dt, 14.7, 8.9)
17 99.2 s 99.1 s
18 0.89 (s) 18.7 q 0.90 (s) 18.7 q
19 1.01 (s) 20.1 q 1.27 (s) 19.6 q
20 2.18 (m) 43.9 d 2.18 (m) 43.9 d
21 1.07 (d, 6.8) 18.7 q 1.06 (d, 6.8) 18.7 q
22 2.52 (dd, 14.1, 6.5) 38.5 t 2.52 (dd, 13.9, 6.5) 38.4 t
2.69 (d, 14.1) 2.70 (d, 13.9)
23 117.0 s 117.0 s
24 4.34 (d, 4.4) 77.4 d 4.35 (dd, 4.7, 3.8)a 77.4 d
25 3.27 (m) 41.3 d 3.28 (m) 41.3 d
26 178.9 s 178.8 s
27 1.47 (d, 7.1) 9.0 q 1.47 (d, 7.1) 9.0 q
28 1.52 (s) 23.4 q 1.47 (s) 20.7 q
29 3.70 (d, 11.0) 64.5 t 3.85 (d, 11.2) 65.1 t
4.56 (d, 11.0) 4.42 (d, 11.2)
30 1.24 (s) 26.0 q 1.23 (s) 25.9 q
a Coupling constants derived from 24-OH [7.89 (d, 4.7)] and H-25
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correlations of H-24 $ Me-21, H-25 $ Me-30 and Me-
30 $ H-15a were indicative of a-orientation of these pro-
tons, while the correlations of Me-18 $ H-20/H-11b
indicative of their b-orientation. Therefore, the structure of 1
was determined as 17a,23a-epoxy-3b,24b,29-trihydroxy-
lanost-8-en-26,23-olide and named scillascillol.
Compound 2 was isolated as a white amorphous powder.
The HRESIMS (neg.) at m/z 499.3053 [M - H]- (calcd
for C30H43O6, 499.3060) indicated the molecular formula
C30H44O6, corresponding to nine degrees of unsaturation.
By comparison with the reported NMR data [17, 18], the
signals of characteristic five-membered spiro rings, a tetra-
substituted double bond and six methyls were detected as
before, which indicated that 2 had a very similar structure
to scillascillol (1). The main difference is only that 2 had a
newly arising keto carbon [dC 214.5 (s)] instead of the
oxygenated methine signal [dH 3.61 (dd, J = 11.6, 4.4 Hz);
dC 80.0 (d)] at C-3 of 1. Thus, compound 2 should be the
3-dehydro derivative of 1. And this was confirmed by the
HMBC correlations from H-1 to C-3, C-5, C-9 and C-10, as
well as from Me-28 and H-29 to C-3, C-4 and C-5.
Therefore, the structure of 2 was determined as 24b,29-
dihydroxy-17a,23a-epoxy-3-oxolanost-8-en-26,23-olide
and named scillascillone.
Compound 3 was also obtained as a white amorphous
powder, and its molecular formula was deduced to be
C40H64O13 based on its negative-ion HRESIMS at m/z
751.4261 [M - H]- (calcd for C40H63O13, 751.4269). The
1H NMR spectrum (Table 2) of 3 was characterized by
signals due to four tertiary methyls [dH 1.48 (s), 1.47 (s),
0.90 (s), 0.87 (s)], one secondary methyl [dH 1.00 (d,
J = 6.6 Hz)], one primary methyl [dH 1.05 (t,
J = 7.3 Hz)], and two anomeric protons [dH 4.98 (d,
J = 7.9 Hz); 4.92 (d, J = 7.0 Hz)]. The 13C NMR spec-
trum (Table 2) of 3 implied the presence of a tetra-sub-
stituted double bond [dC 135.2 (s), 134.6 (s)], one keto
carbonyl [dC 212.6 (s)], and two anomeric carbons [dC
106.2 (d), 105.6 (d)]. On the other hand, a set of additional
11 oxygenated carbons were detected by comparison with
those of 15-deoxoeucosterol (4), suggesting the presence of
a hexose and a pentose. The assignment of the hexose as
C-6 glycosylated glucopyranosyl was launched by obser-
vation of a set of specific oxygenated carbons at [dC 106.2
(d), 75.4 (d), 78.7 (d), 72.0 (d), 77.1 (d), 69.9 (t)] and a
diagnostic glycosidation shift (D & ?8 ppm) of C-6 of
glucopyranosyl. It was still supported by the detailed
HMBC analysis and comparison with the reported spectral
data [19]. The remaining carbons at [dC 105.6 (d), 72.3 (d),
74.4 (d), 69.3 (d), 66.7 (t)] were established as a terminal a-
L-arabinopyranosyl unit by analysis of coupling constants
of sugar moiety (Fig. 3), in which axial–axial couplings
between H-1 and H-2 (J = 7.0 Hz), and between H-2 and
H-3 (J = 8.5 Hz), and axial-equatorial coupling between
H-3 and H-4 (J = 2.8 Hz) were clearly observed. And the
above-mentioned NMR feature was also consistent with the
reported spectral data [20, 21]. In addition, on acid
hydrolysis, 3 afforded monosaccharides in the aqueous
layer, which were found to be identical with authentic
samples of L-arabinose and D-glucose by chiral HPLC
analysis. The connection of these units was established by
the HMBC correlations from the anomeric proton of the
arabinopyranosyl at [dH 4.92 (d, J = 7.0 Hz)] to C-6 of the
glucopyranosyl at [dC 69.9 (t)], and from the anomeric
proton of the glucopyranosyl at [dH 4.98 (d, J = 7.9 Hz)]
to C-3 of the aglycone at [dC 88.9 (d)]. Thus, compound 3
was concluded to be 15-deoxoeucosterol 3-O-a-L-ara-
binopyranosyl-(1 ? 6)-b-D-glucopyranoside, and named
scillascilloside B-1.
Compound 6, a yellow amorphous powder, had a
molecular formula of C16H14O7 based on HRESIMS (neg.)
at m/z 317.0665 [M - H]- (calcd for C16H13O7,
317.0661). The 1H NMR spectrum (Table 3) indicated the
presence of two methoxy signals [dH 3.72 (s), 3.81 (s)], one
aromatic methyl [dH 2.66 (s)], two aromatic singlets [dH
6.41, 6.69], and three low-field exchangeable proton sin-
glets at [dH 10.73, 10.79, 13.44]. The
13C NMR spectrum
(Table 3) displayed a total of 16 carbon resonances
ascribable to two benzene rings, two methoxy group [dC
Fig. 2 Key HMBC ( ) and ROESY ( ) correlations of 1
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60.0 (q), 60.8 (q)], one methyl [dC 22.8 (q)], and one
carbonyl carbon [dC 182.1 (s)]. The above NMR spectro-
scopic features were very similar to those of drimiopsin I
[22], and the most significant difference was from an
additional methoxy signal in 6. The methoxy group was
positioned at C-2 according to the HMBC correlations
(Fig. 4) from 1-OH at [dH 13.44 (s)] and 2-OCH3 at [dH
3.72 (s)] to C-2 at [dC 130.6 (s)]. All of these data for 6
were consistent with the structure 2,5-dimethoxy-8-
methyl-1,3,6-trihydroxyxanthone.
It was worth mentioning that the 1H NMR data of 6 were
identical to drimiopsinD (6a) isolated byD.A.Mulholland from
Drimiopsis maculata [15]. However, there were some deviation
in aspect of the 13CNMRdata of 6 and 6a.We believed that the
13C NMR data of 6a should be measured in CD3OD. This
inference was subsequently confirmed, in view of the complete
consistency of the spectral data of 6 and 6a, when we re-tested
its 13C NMR using CD3OD as deuterated solvent. As a con-
clusion, the structure of drimiopsin D (6a) was revised as 2,5-
dimethoxy-8-methyl-1,3,6-trihydroxyxanthone (6) (Fig. 5).
Table 2 NMR spectroscopic data of scillascilloside B-1 (3) in pyridine-d5 (dH 8.71, dC 149.9 ppm)
No. dH dC No. dH dC
1 1.12 (m) 35.7 t 20 2.02 (m) 43.7 d
1.64 (m) 21 1.00 (d, 6.6) 17.3 q
2 2.03 (m) 27.6 t 22 1.75 (m) 36.9 t
2.39 (m) 1.98 (m)
3 3.50 (dd, 11.7, 4.6) 88.9 d 23 4.63 (dd, 10.4, 7.4) 81.7 s
4 44.4 s 24 212.6 s
5 1.11 (br. d, 11.7, 4.6) 51.7 d 25 2.54 (m) 32.4 t
6 1.42 (m) 18.7 t 26 1.05 (t, 7.3) 7.8 q
1.75 (m) 28 1.47 (s) 23.1 q
7 1.99 (m) 26.9 t 29 3.63 (d, 11.1) 63.2 t
8 135.2 s 4.45 (d, 11.1)
9 134.6 s 30 1.48 (s) 26.5 q
10 36.7 s 10 4.98 (d, 7.9) 106.2 d
11 1.90 (m) 21.1 t 20 3.95 (dd, 7.9, 8.6) 75.4 d
2.06 (m) 30 4.21 (t, 8.6) 78.7 d
12 1.40 (m) 25.3 t 40 4.12 (t, 8.6) 72.0 d
2.34 (m) 50 4.15 (m) 77.1 d
13 48.9 s 60 4.28 (m) 69.9 t
14 50.8 s 4.92 (m)
15 1.38 (m) 32.1 t 100 4.92 (d, 7.0) 105.6 d
1.63 (m) 200 4.47 (dd, 8.5, 7.0) 72.3 d
16 1.59 (m 39.8 t 300 4.17 (dd, 8.5, 2.8) 74.4 d
2.16 (m) 400 4.31 (br. s) 69.3 d
17 97.1 s 500 3.74 (br. d, 10.5) 66.7 t
18 0.87 (s) 19.3 q 4.30 (br. d, 10.5)
19 0.90 (s) 19.6 q
Fig. 3 Chair conformation of
sugar moiety in 3
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3 Experimental
3.1 General Experimental Procedures
Optical rotations were measured on Jasco P-1020 or
SGW-3 (INESA Instrument Co., Ltd., Shanghai, China)
automatic digital polarimeter. UV data were obtained from
HPLC online analysis. IR spectra (KBr) were obtained on a
Bruker Tensor-27 infrared spectrophotometer. NMR spec-
tra were carried out on a Bruker Avance III 600 or Bruker
AV-400 (Bruker BioSpin GmbH, Rheinstetten, Germany)
spectrometer with deuterated solvent signals used as
internal standards. ESIMS and HRESIMS were measured
using Bruker HCT Esquire 3000 and API QSTAR time-of-
flight mass spectrometers, respectively. Silica gel (200–300
mesh, Qingdao Marine Chemical Inc., China), MCI gel
CHP-20P (75–150 lm, Mitsubishi Chemical Corporation,
Japan), Chromatorex C-18 (40–75 lm, Fuji Silysia
Chemical Ltd., Japan) and Sephadex LH-20 (Amersham
Biosciences, Sweden) were used for column chromatog-
raphy. Fractions were monitored and analyzed using TLC,
in combination with Agilent 1200 series HPLC system
equipped by Extend-C18 column (5 lm, 4.6 9 150 mm).
A TCI Chiral MB-S column (5 lm, 4.6 9 250 mm, Tokyo
Chemical Industry Co., Ltd., Tokyo, Japan) was applied for
determination of acid hydrolyzates using Agilent 1200
series HPLC system with an external Alltech 3300 ELSD
detector (Grace, Deerfield, USA).
3.2 Plant Material
The whole plants of S. scilloides were collected from He
County of Anhui Province, China, in August 2009, and
identified by Prof. Shou-Jin Liu of Anhui University of
Chinese Medicine. A voucher specimen (No.
BBP0208018SS) was deposited at BioBioPha Co., Ltd.
3.3 Extraction and Isolation
The dried and crushed whole plants of S. scilloides (9.5 kg)
were extracted with EtOH-H2O (95:5, v/v; 3 9 18 L, each
7 days) at room temperature, and the solvent was removed
under reduced pressure to give crude extract (ca. 1.9 kg),
which was fractionated by silica gel CC successively eluted
with a gradient of increasing acetone in petroleum ether
(PE) (15:1, 10:1, 7:1, 4:1, 2:1, 1:1, 0:1; v/v) and then
MeOH to afford fractions A–H, respectively. Fraction B
was isolated by Sephadex LH-20 CC (CHCl3/MeOH; 1:1)
and repeated silica gel CC (CHCl3/MeOH; 100:0 ?
100:1) to yield 5 (181 mg). Fraction C was further
Table 3 NMR spectroscopic data of drimiopsin D (6)
No. 6a 6b
dH dC dH dC
1 154.6 s 155.9 s
2 130.6 s 131.9 s
3 158.0 s 158.9 s
4 6.41 (s) 93.5 d 6.37 (s) 94.4 d
4a 151.7 s 153.3 s
5 132.8 s 134.2 s
6 155.2 s 156.4 s
7 6.69 (s) 116.0 d 6.61 (s) 116.8 d
8 136.2 s 138.5 s
8a 111.1 s 113.0 s
9 182.1 s 183.9 s
9a 102.3 s 104.1 s
10a 151.7 s 153.7 s
8-CH3 2.66 (s) 22.8 q 2.70 (s) 23.3 q
2-OCH3 3.72 (s) 60.0 q 3.85 (s) 60.9 q
5-OCH3 3.81 (s) 60.8 q 3.90 (s) 61.7 q
1-OH 13.44 (s)
3-OH 10.79 (br. s)
6-OH 10.73 (br. s)
a Measured in DMSO-d6 (dH 2.49, dC 39.5 ppm)
b Measured in CD3OD (dH 3.30, dC 49.0 ppm)
Fig. 4 Key HMBC ( ) correlations of 6
Fig. 5 Structure revision of
drimiopsin D
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separated by silica gel CC (CHCl3/MeOH; 100:1 ? 20:1),
Sephadex LH-20 (MeOH) and preparative TLC (PE/
EtOAc; 8:1) to provide 2 (49 mg), 4 (474 mg) and 8
(45 mg). Fraction D was applied repeatedly to RP-18 CC
(MeOH/H2O; 60 ? 90 %) and then by Sephadex LH-20
(MeOH) to afford 1 (40 mg), 6 (127 mg) and 7 (116 mg).
Compound 3 (291 mg) was eventually acquired by means
of repeated silica gel CC (CHCl3/MeOH; 30:1 ? 10:1),
RP-18 (MeOH/H2O; 40 ? 70 %) and Sephadex LH-20
(CHCl3/MeOH; 1:1) from the fraction F.
3.4 Scillascillol (1)
White amorphous powder; [a]D
25 -0.7 [c 0.42, MeOH-
CHCl3 (1:1)]; IR (KBr) mmax: 3441, 3432, 2943, 2880,
1765, 1631, 1455, 1374, 1321, 1116, 1036, 997, 944,
923 cm-1; 1H and 13C NMR data: see Table 1; ESIMS
(pos.): m/z 525 [M ? Na]?; HRESIMS (neg.): m/z
501.3207 [M - H]- (calcd for C30H45O6, 501.3216).
3.5 Scillascillone (2)
White amorphous powder; [a]D
25 ?46.0 (c 0.25, MeOH); IR
(KBr) mmax: 3471, 2960, 2943, 1765, 1702, 1639, 1456,
1381, 1320, 1115, 1046, 998, 943, 923 cm-1; 1H and 13C
NMR data: see Table 1; ESIMS (pos.): m/z 523
[M ? Na]?; HRESIMS (neg.): m/z 499.3053 [M - H]-
(calcd for C30H43O6, 499.3060).
3.6 Scillascilloside B-1 (3)
White amorphous powder; [a]D
25 -57.9 (c 0.30, MeOH); IR
(KBr) mmax: 3440, 2940, 2883, 1774, 1725, 1713, 1633,
1456, 1376, 1255, 1078, 1048, 1010, 755 cm-1; 1H and 13C
NMR data: see Table 2; ESIMS (pos.): m/z 775
[M ? Na]?; HRESIMS (neg.): m/z 751.4261 [M - H]-
(calcd for C40H63O13, 751.4269).
3.7 2,5-Dimethoxy-8-methyl-1,3,6-trihydroxyxanthone
(= drimiopsin D, 6)
Yellow amorphous powder; UV (MeOH) kmax: 247, 276
(sh), 321 nm; IR (KBr) mmax: 3443, 2959, 2849, 1650,
1619, 1579, 1513, 1461, 1320, 1292, 1267, 1186, 1162,
1105, 992, 816, 796 cm-1; 1H and 13C NMR data: see
Table 3; ESIMS (pos.): m/z 341 [M ? Na]?; HRESIMS
(neg.): m/z 317.0665 [M - H]- (calcd for C16H13O7,
317.0661).
3.8 Acid Hydrolysis of 3
Compound 3 (3 mg) was heated in 2 M HCl (3 mL) at a
temperature of 45 C for 4 h. After cooling, the reaction
mixture was neutralized with KOH to a pH of approxi-
mately 7, and then extracted with EtOAc. The aqueous
layer was analyzed by HPLC under the following condi-
tions: solvent, n-hexane/isopropanol (85:15); flow rate,
1.0 ml/min; temperature, 25 C. The retention times (tR) of
D-glucose and L-arabinose were 5.5 and 6.9 min,
respectively.
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